Pretzel Therapeutics

About:

Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.

Website: https://www.pretzeltx.com/

Top Investors: Cambridge Innovation Capital, ARCH Venture Partners, Google Ventures, Invus, HealthCap

Description:

Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

Total Funding Amount:

$72.5M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Claes Gustafsson, Gabriel Martinez, Maria Falkenberg, Michal Minczuk

Number of Employees:

11-50

Last Funding Date:

2022-09-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai